ECNP Mini-Conference at FENS
ECNP Mini-Conference at the 12th FENS Forum of Neuroscience
Saturday 11 July 2020, 10.00-15.00
As a consequence of the corona crisis, the FENS Forum 2020 will be held entirely virtually. More info here
Neuroscience applied and translational research
The ECNP Mini-Conference showcases the most exciting research in applied and translational neuroscience.
Four leading experts will present the latest developments in the field, showing the advances being made in translating basic neuroscience findings into real-world clinical applications for patients.
Registration is free, please use the button below to confirm your attendance.
In case of questions regarding the registration, you can send us an e-mail.
||Welcome and introduction to ECNP
||Elisabeth Binder – Embedding of early adversity – implications for risk trajectories in psychiatry
||John Cryan – Brain-body mechanisms in psychiatry: translational hurdles
|| Martien Kas – Linking neuropsychiatry to quantitative biology
||Andreas Meyer-Lindenberg – Precision prevention through characterising neural mechanisms
of environmental risk
||Panel discussion – Future outlook on neuroscience applied research to provide solutions to the
growing public health challenges of psychiatry and neurology
Director, Department Translational Research in Psychiatry
Max Planck Institute of Psychiatry
ECNP Vice president
John F. Cryan
Professor and Chair, Department of Anatomy and Neuroscience and Principal Investigator, APC Microbiome
University College Cork, Ireland
Professor of Behavioural Neuroscience, Groningen Institute for Evolutionary Life Sciences
University of Groningen, the Netherlands
Director, Central Institute of Mental Health, Mannheim
Medical Director, Department of Psychiatry and Psychotherapy
Chair of Psychiatry and Psychotherapy
University of Heidelberg, Germany
The European College of Neuropsychopharmacology (ECNP) is committed to ensuring that advances in the understanding of brain function and behaviour are translated into better treatments for brain disorders and enhanced public health. To achieve these goals, ECNP supports innovative research in neuroscience applied disciplines and facilitate the communication of ideas, discoveries and best practices. In addition, ECNP promotes the entry of early career scientists into the field and support their ongoing professional development, provides guidance and information to the public, and facilitate dialogue with regulators, government bodies, international agencies and industry.
Follow these links to find out more about ECNP and the ECNP Congress, Europe’s largest meeting in applied and translational neuroscience.